Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2024Movement Disorders Clinical Practice

Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDiego Santos‐GarcíaUniversidade da CoruñaTDTeresa de DeusComplejo Hospitalario Universitario de FerrolCCCarlos Cores

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santos‐García et al. (2024) studied this question.

synapsesocial.com/papers/68e69ff0b6db643587623628https://doi.org/10.1002/mdc3.14056
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Assessment of Clinical and Demographic Factors Influencing the Severity of Levodopa-Induced Dyskinesia2025
  2. 2L‐<scp>DOPA</scp>‐induced dyskinesias, motor fluctuations and health‐related quality of life: the <scp>COPARK</scp> survey2017 · 54 citations
  3. 3EPIDEMIOLOGY OF LEVODOPA-INDUCED DYSKINESIA: PREVALENCE AND ASSOCIATED CLINICAL FACTORS IN LATIN AMERICA2025
  4. 4Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort2026
  5. 5Placebo Effect in Levodopa‐Induced Dyskinesia: A Systematic Review and Meta‐Analysis2026